Cell and gene therapy services

Accelerate cell and gene therapy innovation

Providers, manufacturers, sponsors, and Contract Development and Manufacturing Organizations (CDMOs) face a multitude of challenges in the cell and gene therapy space. Disparate portals, time-intensive onboarding, high costs, and limited collaboration create a fractured experience in one of the fastest-growing industries within life sciences.<br><br> Our cell and gene therapy services put patients at the center of care with clear visibility into Chain or Identity (COI) and Chain of Custody (COC) across industry stakeholders, helping you optimize the coordination of your entire CGT ecosystem to drive <a href="/us/en/pages/about-deloitte/solutions/industry-advantage-business-transformation.html" target="_blank">IndustryAdvantage™</a> and enhance the patient treatment journey.

supporting callout image

Converge ecosystem and alliances

Our curated ecosystem of data and technology vendors aligns to the challenges we’re helping you address to reduce complexity and deliver outcomes that prepare you for the future. By incorporating new innovations from our ecosystem and continuously investing in our industry cloud platforms, our customizable solutions can help you achieve IndustryAdvantage™.

supporting callout image

Ready to move forward?

We'd love to hear about your needs and business challenges, even if you're not sure what your next step should be.

Insert Custom HTML fragment. Do not delete! This box/component contains code that is needed on this page. This message will not be visible when page is activated.
+++ DO NOT USE THIS FRAGMENT WITHOUT EXPLICIT APPROVAL FROM THE CREATIVE STUDIO DEVELOPMENT TEAM +++